摘要
The discovery and development of CDK2 inhibitors has currently been validated as a hot topic in cancer therapy. Herein, a series of novel N-(pyridin-3-yl)pyrimidin-4-amine derivatives were designed and synthesized as potent CDK2 inhibitors. Among them, the most promising compound 7l presented a broad antiproliferative efficacy toward diverse cancer cells MV4-11, HT-29, MCF-7, and HeLa with IC50 values of 0.83, 2.12, 3.12, and 8.61 mu M, respectively, which were comparable to that of Palbociclib and AZD5438. Interestingly, these compounds were less toxic on normal embryonic kidney cells HEK293 with high selectivity index. Further mechanistic studies indicated 7l caused cell cycle arrest and apoptosis on HeLa cells in a concentration-dependent manner. Moreover, 7l manifested potent and similar CDK2/cyclin A2 nhibitory activity to AZD5438 with an IC50 of 64.42 nM. These findings revealed that 7l could serve as a highly promising scaffold for CDK2 inhibitors as potential anticancer agents and functional probes.
学科与关键词
- Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activityLi, Qiu; Chen, Lin; Ma, Yu-Feng; Jian, Xie-Er; Ji, Jia-Hao; You, Wen-Wei; Zhao, Pei-Liang*Bioorganic Chemistry, 2021, 116: 105324.被引 7
- Design, synthesis and antiproliferative activity of novel 2,4-diamino-5--methyleneaminopyrimidine derivatives as potential anticancer agentsLi, Qiu; Chen, Lin; Jian, Xie-Er; Lv, Dong-Xin; You, Wen-Wei; Zhao, Pei-Liang*Bioorganic and Medicinal Chemistry Letters, 2021, 47: 128213.被引 6
- Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery EffortsXie, Zhouling; Hou, Shuzeng; Yang, Xiaoxiao; Duan, Yajun; Han, Jihong; Wang, Qin*; Liao, Chenzhong*Journal of Medicinal Chemistry, 2022, 65(9): 6356-6389.被引 21
